Strategic partnership Beverly Hills Cancer Center has recently partnered with Select Healthcare Solutions to integrate SCINTIX therapy, signaling openness to advanced treatment modalities and technology-enabled collaborations that can open doors for additional vendor and integration opportunities.

EMR and data Existing integrations with Deep Lens VIPER and connections to Foundation Medicine, Caris Life Sciences, Tempus, and Guardant Health indicate a mature data and analytics ecosystem, presenting opportunities for software, data analytics services, and AI-driven trial matching solutions.

Private comprehensive As the only private comprehensive cancer treatment facility in Southern California with in-house radiation, infusion, imaging, and diagnostics, BHCC represents a consolidated platform ideal for end-to-end solution selling, including equipment, AI-enabled imaging, and integrated oncology IT systems.

Clinical trial focus BHCC conducts leading clinical trials and emphasizes patient-centric care, suggesting sales opportunities around patient recruitment solutions, trial management software, and partnerships with CROs or biopharma for trial expansion and site services.

Financial scale With estimated revenue in the 10–25 million range and a mid-sized employee base, BHCC is a target for scalable, mid-market oncology technology, service contracts, and outbound outreach that align with growing cancer centers seeking cost-effective, high-impact solutions.